check
Molecular Medicine in the Service of Mankind: Towards the 2000s | Israel Institute for Advanced Studies

Molecular Medicine in the Service of Mankind: Towards the 2000s

[RG #82] Molecular Medicine in the Service of Mankind: Towards the 2000s

November 1, 2000 - January 31, 2001

Organizer:

Alexander Levitzki (The Hebrew University of Jerusalem)

The group on molecular medicine focused on the role of the new developments in molecular biology and biochemistry in the revolution in medicine which is now taking place. These new developments, including the publication of the human genome, create new opportunities for the improvement of human health. The group's work will concentrate on the ramifications of these technological revolutions for new approaches to the treatment of various cancers and other diseases in which cellular communications fail. 

The group will focus primarily on the molecular mechanisms of cell signaling, that is, how cells communicate between themselves and how cells transmit information into the cell. The group will also explore ways to remedy the aberrations in these communication networks which occur in the course of disease. The knowledge of how cell communication works will allow the development of novel therapies.

 

Members

men

Anthony Burgess

FELLOW
The Ludwig Institute for Cancer
Anthony is a professor in the Ludwig Institute for Cancer, Melbourne. His research interests are: The molecular mechanisms of signal transduction on the EGF receptor. Within this frame of interest the three dimensional stucture of the EGF receptor ligand TGF has been solved.
men

Benjamin Geiger

FELLOW
The Weizmann Institute of Science
Benjamin is a professor in the Department of Molecular Cell Biology at the Weizmann Institute of Science.
men

Eli Keshet

FELLOW
The Hebrew University of Jerusalem
Eli is a professor in the Department of Molecular Biology at The Hebrew University of Jerusalem.
men

Alexander Levitzki

FELLOW
The Hebrew University of Jerusalem
Alexander is a professor in the Department of Biological Chemistry at The Hebrew University of Jerusalem.
men

Wouter Moolenaar

FELLOW
The Netherlands Cancer Institute
Wouter is a professor in the Division of Cellular Biochemistry at the Netherlands Cancer Institute, Amsterdam. His research interests are: cell regulation and signaling by G protein-coupled receptors, particularly those for bioactive lysophospholipids.
men

Joseph Schlessinger

FELLOW
NYU Medical Center
Joseph is a professor in the Department of Pharmacology at NYU Medical Center. His research interests are: The mechanism of action of receptor tyrosine kinases and analysis of the signaling pathways they activate.

Events